- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
FSD Pharma Inc Class B is a drug manufacturers - specialty & generic business based in the US. FSD Pharma Inc Class B shares (HUGE) are listed on the NASDAQ and all prices are listed in US Dollars.
What's in this guide?
Our top picks for where to buy FSD Pharma Inc Class B stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy FSD Pharma Inc Class B stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – HUGE. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy FSD Pharma Inc Class B stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
FSD Pharma Inc Class B stock price (NASDAQ: HUGE)
Use our graph to track the performance of HUGE stocks over time.FSD Pharma Inc Class B shares at a glance
Information last updated 2024-12-15.
| 52-week range | $3.50 - $70.85 |
|---|---|
| 50-day moving average | $8.13 |
| 200-day moving average | $36.69 |
| Wall St. target price | $2.60 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-16.25 |
Is it a good time to buy FSD Pharma Inc Class B stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
FSD Pharma Inc Class B financials
| Gross profit TTM | $-3,331,945 |
|---|---|
| Return on assets TTM | -36.47% |
| Return on equity TTM | -63.89% |
| Profit margin | 0% |
| Book value | $17.09 |
| Market Capitalization | $66,671 |
TTM: trailing 12 months
FSD Pharma Inc Class B share dividends
We're not expecting FSD Pharma Inc Class B to pay a dividend over the next 12 months.
Have FSD Pharma Inc Class B's shares ever split?
FSD Pharma Inc Class B's shares were split on a 1:65 basis on 14 August 2024 . So if you had owned 65 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your FSD Pharma Inc Class B shares – just the quantity. However, indirectly, the new 6400% higher share price could have impacted the market appetite for FSD Pharma Inc Class B shares which in turn could have impacted FSD Pharma Inc Class B's share price.
FSD Pharma Inc Class B share price volatility
Over the last 12 months, FSD Pharma Inc Class B's shares have ranged in value from as little as $3.5 up to $70.85. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while FSD Pharma Inc Class B's is 0.848. This would suggest that FSD Pharma Inc Class B's shares are less volatile than average (for this exchange).
FSD Pharma Inc Class B overview
FSD Pharma Inc. , a biopharmaceutical company, researches and develops a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company operates through two segments, Biopharmaceutical and Strategic Investments. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company is also developing a treatment for alcohol misuse for application in hospitals and other medical practices. In addition, it maintains a portfolio of strategic investments comprising loans secured by residential property. FSD Pharma Inc.
Frequently asked questions
nullWhat percentage of FSD Pharma Inc Class B is owned by insiders or institutions?
Currently 9.741% of FSD Pharma Inc Class B shares are held by insiders and 2.691% by institutions. When does the fiscal year end for FSD Pharma Inc Class B?
FSD Pharma Inc Class B's fiscal year ends in December. Where is FSD Pharma Inc Class B based?
FSD Pharma Inc Class B's address is: 55 University Ave., Toronto, ON, Canada, M5J 2H7 What is FSD Pharma Inc Class B's ISIN number?
FSD Pharma Inc Class B's international securities identification number is: CA35954B2066 What is FSD Pharma Inc Class B's CUSIP number?
FSD Pharma Inc Class B's Committee on Uniform Securities Identification Procedures number is: 35954B206
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question